E-Cigarettes & Seizures: Is There a Link?

On-the-job Employee Exposure To Hazardous Materials & Lung Cancer
August 19, 2019
Pharma Company Pays $10M to Exit Opioid Bellwethers
August 21, 2019
juul e-cigarette seizure risk

If you experienced seizures after using e-cigarettes, the FDA wants to hear from you

In an effort to gather more information on how e-cigarettes affect health, the U.S. Food and Drug Administration (FDA) is again calling on people to submit adverse event reports if they had a seizure after using e-cigarettes. 

The FDA issued a brief on Aug. 7 asking for continued submissions of adverse event reports specifically about seizures and other neurological symptoms to help its ongoing scientific investigation into the safety of e-cigarettes.

The FDA is continuing its scientific investigation to determine if there’s a direct relationship between the use of e-cigarettes and a risk of seizure or other neurological symptoms. Although we still don’t have enough information to determine if e-cigarettes are causing these reported incidents, we believe it’s critical to keep the public updated on the information we’ve received based on the agency’s initial request for reports earlier this year,” the agency wrote. 

The safety of e-cigarettes, including the popular JUUL vape pens, have been called into question by researchers, health agencies, and users alike. Studies have linked e-cigarettes to increased risk of heart disease, lung problems, and neurological problems like seizures.

E-cigarette users who developed severe health problems are now filing lawsuits against Juul Labs, the maker of Juul vape pens, and other e-cigarette manufacturers like Blu, NJOY, Vuse, Joyetech, and Apollo. 

E-Cigarettes and Seizures: Submit Your Adverse Event Report

If you experienced seizures, neurological symptoms, or the health issues after using e-cigarettes, you should submit an adverse event report to the FDA. These reports help the FDA determine what products are unsafe to consumers. 

To submit your report, visit the FDA’s Safety Reporting Portal and follow the prompts.